The five-year overall survival with positive and negative PD-L1 in carcinoma cells was 47.1% and 72.9%, respectively (χ2 = 6.51, p-value = 0.0107) in Cohort 2 (Figure 3d). This evidence concerns the gene CD274 and carcinoma.